Skip to content
thispeptide

StaveMD

StaveMD identifies OpenLoop’s clinical network and four dispensing partners. Before-refill check-ins and round-the-clock support are described, while the public laboratory plan remains incomplete.

Review by Leah Garner, clinical-evidence editor · Updated October 2026

The short version

The disclosed clinical network, pharmacy list and refill checks are useful details. Confirm who manages the actual prescription and whether the proposed preparation fits the clinical need. A published support promise is not a measured response-time guarantee.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Lowest listed: Semaglutide injection, from $249 per 4 wks ($269.75 a calendar month, our calendar-month conversion)

Visit StaveMD →

StaveMD is the trading name of RZ International LLC, a California technology platform. It connects adults with independent providers and pharmacies rather than practicing medicine itself. The current menu includes compounded semaglutide injections, tirzepatide injections and semaglutide tablets. Eligibility and available treatment vary by state. The online eligibility check does not guarantee a prescription.

What StaveMD prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)From $249 per 4 wks$269.75 a calendar month, our calendar-month conversion
    • Oral (compounded)From $329 per 4 wks$356.42 a calendar month, our calendar-month conversion
  • TirzepatideFDA-approved
    • Injection (compounded)From $399 per 4 wks$432.25 a calendar month, our calendar-month conversion

The service offers weight management through compounded GLP-1 treatment. Its oral semaglutide and injectable preparations should be discussed separately. A listed compounded product is not the same finished medicine studied under a brand-name trial protocol.

Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.

Who prescribes

A licensed clinician

The terms name OpenLoop Healthcare Partners, PC and affiliated professional corporations as the medical network. They list Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx as possible dispensers. These disclosures do not establish which pharmacy or clinician serves a particular patient. Ask for that assignment and the exact formulation before treatment.

A health intake is reviewed by a licensed provider. Depending on the state, communication may occur through messages or a short video visit. Check-ins before each refill cover weight and symptoms, with a provider adjusting the plan. Support is advertised around the clock through the portal or email. Medical assistants handle initial questions, with nurses and providers available for clinical matters. That is broader than a scheduled physician appointment for every message.

Are labs required?

Not mentioned

No universal laboratory panel, included testing allowance or repeat interval is published on the reviewed offer and agreement pages. Ask whether your history calls for testing and who pays for it. Refill questionnaires do not establish that every clinically relevant measurement is collected.

Ready to start with StaveMD?

Lowest listed price: Semaglutide injection, from $249 per 4 wks ($269.75 a calendar month, our calendar-month conversion). Confirm it on the seller’s own site.

What it claims, and what it cites

The homepage cites major weight-management trials and explicitly says they studied approved brand-name drugs, not StaveMD preparations. Network patient counts are identified as OpenLoop totals. These distinctions should remain beside the stronger promotional headlines. A pharmacy list also needs context. Triad Rx received an FDA warning about sterile-drug practices in 2019. FDA issued a closeout in 2023, acknowledging that sterile production had ceased then. That historical record does not identify today’s dispensing assignment or prove a current prescription is affected.

How it bills

The regular injection amounts are $249 for semaglutide and $399 for tirzepatide; semaglutide tablets are $329. The headline $179 can reflect optional prepayment or a first-fill code. Although offers use monthly language, the cancellation agreement says plans continue every four weeks. A credited $39 evaluation payment is part of an approved plan, not an extra amount to add twice. The policy requires cancellation at least 48 hours before renewal and describes refunds for the latest four-week payment.

For and against

  • For: Medical network and pharmacy list visible
  • For: Check-in before each refill described
  • For: Trial and network figures qualified
  • For: Clinical support escalation explained
  • Against: Laboratory protocol not fully published
  • Against: Actual clinician and pharmacy need confirmation
  • Against: Monthly language differs from four-week renewal
  • Against: Past pharmacy record needs current assignment context

The evidence behind what it sells

Right for

Someone seeking a defined refill check-in process who will verify the clinician, laboratory needs and dispensing pharmacy.

Look elsewhere if

Someone assuming a headline study result describes this platform’s patients or that a support team replaces individualized follow-up.

Other sellers for weight

StaveMD

Frequently asked questions

Who supplies clinical care?
The agreement identifies OpenLoop Healthcare Partners and affiliated professional corporations. Confirm your assigned provider.
What happens before a refill?
The site describes a care-team check-in about weight and symptoms, followed by provider review of the dose.
Are the trial figures StaveMD patient results?
No. The disclosures distinguish approved-drug trials from compounded preparations and identify network figures as OpenLoop totals.

Sources

See what StaveMD prescribes today

StaveMD sets its own prices, plans and the states it serves. Check them before you start.

Written by Leah Garner from StaveMD’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.